Clinical Trials Browser

Phase NA × Prostatic Hyperplasia × 1 year × Clear all

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Bladder, Overactive

NCT07526675 2026-04-13

Bioblation

Phase NA Not yet recruiting

30 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT07510685 2026-04-03

IRIS

Phase NA Completed

240 enrolled

Genitourinary

Urinary Bladder Neoplasms, Prostatic Hyperplasia, Catheter-Related Infections

NCT06051942 2026-01-28

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Phase NA Active not recruiting

125 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT05148156 2026-01-27

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Phase NA Suspended

20 enrolled

Genitourinary

Prostatic Hyperplasia, Nocturia, Dysuria

NCT07071207 2025-11-06

TextMsgM-ISI

Phase NA Recruiting

132 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Incontinence, Stress

NCT07115992 2025-08-26

PRESEL

Phase NA Recruiting

270 enrolled

Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT04853914 2025-06-05

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.

Phase NA Completed

9 enrolled

Genitourinary

Adenoma, Prostatic Hyperplasia

Clinical Trials

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Bioblation

IRIS

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

TextMsgM-ISI

PRESEL

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.